ARCHIVES

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes

March 4, 1988

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986